Advertisement
Studies find mTOR inhibitor may play key role in treating Hurthle cell carcinoma
Dynamic risk assessment may aid clinicians in helping support informed treatment decisions
A new study indicates that the combined approaches can be performed without mortality and with acceptable morbidity
New research provides clinical insight into prognostic factors
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A significant number of patients initially referred for unilateral thyroid lobectomy end up needing complete thyroidectomy
Study of a family with Cowden Syndrome, thyroid cancer
Referral network for inherited cancer syndromes
Advertisement
Advertisement